Abstract
Awake craniotomies are increasingly applied during resective glioma surgery. Even though the technique has had a significant impact on patient care, several questions regarding its efficacy and risks remain to be elucidated. This poses a challenge to the neurosurgical community, as the use of large randomized trials may be infeasible. The Institute of Medicine has recently introduced the learning health system, a system that aims to facilitate continuous learning activities by tempering the traditional dividing line between clinical research and clinical care. Here, we aim to identify the various challenges associated with evaluating awake craniotomies in glioma patients and to propose the learning healthcare system and its associated ethics framework as a potential solution.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Greenblatt S. A history of neurosurgery: in its scientific and professional contexts. New York: Thieme; 1997. p. 23–5.
Olsen L, Aisner D, McGinnis JM. The learning healthcare system: workshop summary (IOM roundtable on evidence-based medicine). Washington DC: National Academies Press; 2007.
Broekman ML, Carrière ME, Bredenoord AL. Surgical innovation: the ethical agenda: a systematic review. Medicine (Baltimore). 2016;95(25):e3790.
McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. The Lancet. 2009;374:1105–12.
Brown T, Shah AH, Bregy A, Shah NH, Thambuswamy M, Barbarite, et al. Awake craniotomy for brain tumor resection: the rule rather than the exception? J Neurosurg Anesthesiol. 2013;25:240–7.
Kirsch B, Bernstein M. Ethical challenges with awake craniotomy for tumor. Can J Neurol Sci. 2012;39:78–82.
Serletis D, Bernstein M. Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors. J Neurosurg. 2007;107:1–6.
Bernstein M. Fully informed consent is impossible in surgical clinical trials. Can J Surg. 2005;48:271.
Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hast Cent Rep. 1987;17:20–4.
Kass NE, Faden RR, Goodman SN, Pronovost P, Tunis S, Beauchamp TL. The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight. Hast Cent Rep. 2013;43:4–15.
Faden RR, Kass NE, Goodman SN, Pronovost P, Tunis S, Beauchamp TL. An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics. Hast Cent Rep. 2013;43:16–27.
Ford PJ. Vulnerable brains: research ethics and neurosurgical patients. J Law Med Ethics. 2009;37:73–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lutters, B., Broekman, M.L.D. (2019). Evaluating Awake Craniotomies in Glioma Patients: Meeting the Challenge. In: Broekman, M. (eds) Ethics of Innovation in Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-030-05502-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-05502-8_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05501-1
Online ISBN: 978-3-030-05502-8
eBook Packages: MedicineMedicine (R0)